The DOI matches its Crossref record; 73 of the 74 references it cites were found in a registry or an index.
Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans
Abstract
In humans, 3beta-hydroxysteroid dehydrogenase (3beta-HSD), 17beta-HSD and 5alpha-reductase activities in androgen target tissues, such as the prostate and skin, convert dehydroepiandrosterone, androstenedione and testosterone into the most potent natural androgen dihydrotestosterone (DHT). This androgen is converted mainly in situ into two phase I metabolites, androsterone (ADT) and androstane-3alpha,17beta-diol (3alpha-DIOL), which might be back converted to DHT. Here, we discuss the recent findings regarding the characterization of specific UDP-glucuronosyltransferases (UGTs), UGT2B7, B15 and B17, responsible for the glucuronidation of these metabolites. The tissue distribution and cellular localization of the UGT2B transcripts and proteins in humans clearly indicate that these enzymes are synthesized in androgen-sensitive tissues. It is postulated that the conjugating activity of UGT enzymes is the main mechanism for modulating the action of steroids and protecting the androgen-sensitive tissues from deleteriously high concentrations of DHT, ADT and 3alpha-DIOL.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The glucuronidation of C19 steroids is catalyzed by three members of the UGT2B subfamily, namely: UGT2B7, UGT2B15 and UGT2B17 [175].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [175]
In the citing paper
“As opposed to sulfation, glucuronidation is irreversible and ultimately inactivates the androgen and initiates its renal excretion by increasing polarity and water solubility of the molecule (Belanger et al., 2003).”
From Intracrine androgen biosynthesis, metabolism and action revisited (2018) · cites this paper as Belanger et al., 2003
Citations
Cites
Mackenzie, P. I., Owens, I. S., Burchell, B., Bock, K. W., Bairoch, A., Bélanger, A., Fournel‐Gigleux, S., Green, M. D., Hum, D. W., Iyanagi, T., et al. (1997) · Pharmacogenetics · doi:10.1097/00008571-199708000-00001 · Cited by 1,185
Labrie, F. (1991) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(91)90116-a · Cited by 685
Self-citationLabrie, F., Luu-The, V., Labrie, C., Bélanger, A., Simard, J., Lin, S.-X., & Pelletier, G. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0031 · Cited by 544
Role of Hormones in Pilosebaceous Unit Development
Deplewski, D., & Rosenfield, R. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.4.0404 · Cited by 443
Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men
Bèlanger, A., Candas, B., Dupont, A., Cusan, L., Diamond, P., Gomez, J.-L., & Labrie, F. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.4.7962278 · Cited by 437
Zhou, Z. X., Lane, M. V., Kemppainen, J., French, F. S., & Wilson, E. M. (1995) · Molecular Endocrinology · doi:10.1210/mend.9.2.7776971 · Cited by 411
Labrie, F., Bélanger, A., Cusan, L., & Candas, B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4161 · Cited by 350
Self-citationTurgeon, D., Carrier, J.-S., Lévesque, E., Hum, D. W., & Bélanger, A. (2001) · Endocrinology · doi:10.1210/endo.142.2.7958 · Cited by 333
Cutaneous androgen metabolism: basic research and clinical perspectives
Chen, W., Thiboutot, D., & Zouboulis, C. C. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.00613.x · Cited by 273
Azziz, R., Carmina, E., & Sawaya, M. E. (2000) · Endocrine Reviews · doi:10.1210/er.21.4.347 · Cited by 249
Research works printed but not linked: 1
- Turgeon, 2001, Relative enzymatic activity, protein stability and tissue distribution of human steroid metabolizing UGT2B subfamily members, Endocrinology, 142, 778, 10.1210/en.142.2.778 · DOI · Paper page
Cited by
Sorted by citations
Chemistry and Structural Biology of Androgen Receptor
Gao, W., Bohl, C. E., & Dalton, J. T. (2005) · Chemical Reviews · doi:10.1021/cr020456u · Cited by 527
Is dehydroepiandrosterone a hormone?
Labrie, F., Luu-The, V., Bèlanger, A., Lin, S.-X., Simard, J., Pelletier, G., & Labrie, C. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06264 · Cited by 460
Schiffer, L., Barnard, L., Baranowski, E. S., Gilligan, L. C., Taylor, A. E., Arlt, W., Shackleton, C. H. L., & Storbeck, K.-H. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105439 · Cited by 450
“UGT2B17 has highest activity of all UGTs towards An, testosterone and DHT. UGT2A1 may also contribute to the glucuronidation of testosterone [291].”
InfluentialUse of doping agents, particularly anabolic steroids, in sports and society
Sjöqvist, F., Garle, M., & Rane, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60801-6 · Cited by 349
Bile Acid Metabolism and Signaling in Cholestasis, Inflammation, and Cancer
Li, T., & Apte, U. M. (2015) · Advances in pharmacology · doi:10.1016/bs.apha.2015.04.003 · Cited by 336
Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women
Labrie, F., Bélanger, A., Bélanger, P., Bérubé, R., Martel, C., Cusan, L., Gomez, J., Candas, B., Castiel, I., Chaussade, V., et al. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.02.004 · Cited by 299
Jakobsson, J., Ekström, L., Inotsume, N., Garle, M., Lorentzon, M., Ohlsson, C., Roh, H., Carlström, K., & Rane, A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1643 · Cited by 282
The gut microbiota is a major regulator of androgen metabolism in intestinal contents
Colldén, H., Landin, A., Wallenius, V., Elebring, E., Fändriks, L., Nilsson, M. E., Ryberg, H., Poutanen, M., Sjögren, K., Vandenput, L., et al. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00338.2019 · Cited by 257
Dihydrotestosterone: Biochemistry, Physiology, and Clinical Implications of Elevated Blood Levels
Swerdloff, R. S., Dudley, R. E., Page, S. T., Wang, C., & Salameh, W. A. (2017) · Endocrine Reviews · doi:10.1210/er.2016-1067 · Cited by 260
Intracrine androgen biosynthesis, metabolism and action revisited
Schiffer, L., Arlt, W., & Storbeck, K.-H. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.08.016 · Cited by 217
“The expression of UGTs in adipose tissue (Tchernof et al., 1999) and the correlation of plasma 3a-adiol glucuronide with fat mass in men (Tchernof et al., 1997) suggest phase 2 metabolism as final step of androgen inactivation in adipocytes.”
InfluentialLépine, J., Bernard, O., Plante, M., Têtu, B., Pelletier, G., Labrie, F., Bélanger, A., & Guillemette, C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0331 · Cited by 205
Reproducibility of Serum Sex Steroid Assays in Men by RIA and Mass Spectrometry
Hsing, A. W., Stanczyk, F. Z., Bélanger, A., Schroeder, P., Chang, L., Falk, R. T., & Fears, T. R. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0792 · Cited by 190
Anabolic–androgenic steroids: How do they work and what are the risks?
Bond, P., Smit, D. L., & de Ronde, W. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1059473 · Cited by 235
Schulze, J. J., Lundmark, J., Garle, M., Skilving, I., Ekström, L., & Rane, A. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0218 · Cited by 186
Uridine diphosphoglucuronosyltransferase pharmacogenetics and cancer
Nagar, S., & Remmel, R. P. (2006) · Oncogene · doi:10.1038/sj.onc.1209375 · Cited by 173
Intratumoral androgen biosynthesis in prostate cancer pathogenesis and response to therapy
Cai, C., & Balk, S. P. (2011) · Endocrine Related Cancer · doi:10.1530/erc-10-0339 · Cited by 163
Pretorius, E., Africander, D. J., Vlok, M., Perkins, M. S., Quanson, J., & Storbeck, K.-H. (2016) · PLOS ONE · doi:10.1371/journal.pone.0159867 · Cited by 148
The Intracrine Sex Steroid Biosynthesis Pathways
Luu-The, V., & Labrie, F. (2010) · Progress in brain research · doi:10.1016/s0079-6123(08)81010-2 · Cited by 148
A new dawn for androgens: novel lessons from 11-oxygenated C19 steroids
Pretorius, E., Arlt, W., & Storbeck, K.-H. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.08.014 · Cited by 142
Drug discovery in advanced prostate cancer: translating biology into therapy
Yap, T. A., Smith, A. D., Ferraldeschi, R., Al‐Lazikani, B., Workman, P., & Bono, J. S. D. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.120 · Cited by 143
Position Stand on Androgen and Human Growth Hormone Use
Hoffman, J. R., Kraemer, W. J., Bhasin, S., Storer, T. W., Ratamess, N. A., Haff, G. G., Willoughby, D. S., & Rogol, A. D. (2009) · The Journal of Strength and Conditioning Research · doi:10.1519/jsc.0b013e31819df2e6 · Cited by 143
UGT genomic diversity: beyond gene duplication
Guillemette, C., Lévesque, É., Harvey, M., Bellemare, J., & Ménard, V. (2009) · Drug Metabolism Reviews · doi:10.3109/03602530903210682 · Cited by 140
Lycopene reduced gene expression of steroid targets and inflammatory markers in normal rat prostate
Herzog, A., Siler, U., Spitzer, V., Seifert, N., Denelavas, A., Hunziker, P. B., Hunziker, W. H., Góralczyk, R., & Wertz, K. (2004) · The FASEB Journal · doi:10.1096/fj.04-1905fje · Cited by 132
Metabolism of DHEA in postmenopausal women following percutaneous administration
Labrie, F., Bélanger, A., Bélanger, P., Bérubé, R., Martel, C., Cusan, L., Gomez, J., Candas, B., Chaussade, V., Castiel, I., et al. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.09.034 · Cited by 129
Exploring the role of gut microbiome in male reproduction
Wang, Y., & Xie, Z. (2021) · Andrology · doi:10.1111/andr.13143 · Cited by 125
Guillemette, C., Bélanger, A., & Lépine, J. (2004) · Breast Cancer Research · doi:10.1186/bcr936 · Cited by 123
Yang, N., Sun, R., Liao, X., Aa, J., & Wang, G. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.05.001 · Cited by 120
Hussain, T., Murtaza, G., Kalhoro, D. H., Kalhoro, M. S., Metwally, E., Chughtai, M. I., Mazhar, M. U., & Khan, S. A. (2021) · Animal Nutrition · doi:10.1016/j.aninu.2020.11.005 · Cited by 110
Chouinard, S., Barbier, O., & Bélanger, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703370200 · Cited by 109
Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer
Vatapalli, R. J., Sagar, V., Rodríguez, Y., Zhao, J. C., Unno, K., Pamarthy, S., Lysy, B., Anker, J. F., Han, H., Yoo, Y. A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18013-7 · Cited by 111
Park, J.-H., Chen, L., Ratnashinge, L., Sellers, T. A., Tanner, J.-P., Lee, J., Dossett, N., Lang, N. P., Kadlubar, F. F., Ambrosone, C. B., et al. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0141 · Cited by 106
Gut microbiota-gonadal axis: the impact of gut microbiota on reproductive functions
Ashonibare, V. J., Akorede, B. A., Ashonibare, P. J., Akhigbe, T. M., & Akhigbe, R. E. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1346035 · Cited by 107
Evidence for geographical and racial variation in serum sex steroid levels in older men
Orwoll, E. S., Nielson, C. M., Labrie, F., Barrett-Connor, E., Cauley, J. A., Cummings, S. R., Ensrud, K., Karlsson, M., Lau, E., Leung, P. C., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2435 · Cited by 100
Self-citationLabrie, F., Martel, C., Bélanger, A., & Pelletier, G. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.12.007 · Cited by 95
Role of androgens in women's sexual dysfunction
Basson, R. J., Brotto, L. A., Petkau, A. J., & Labrie, F. (2010) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181d59765 · Cited by 100
Molecular Pathways: Inhibiting Steroid Biosynthesis in Prostate Cancer
Ferraldeschi, R., Sharifi, N., Auchus, R. J., & Attard, G. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0931 · Cited by 93
Inactivation by UDP-glucuronosyltransferase enzymes: The end of androgen signaling
Chouinard, S., Yueh, M.-F., Tukey, R. H., Giton, F., Fiet, J., Pelletier, G., Barbier, O., & Bélanger, A. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.03.016 · Cited by 90
Self-citationInactivation of androgens by UDP-glucuronosyltransferases in the human prostate
Barbier, O., & Bélanger, A. (2008) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.01.001 · Cited by 86
Science of intracrinology in postmenopausal women
Labrie, F., Bélanger, A., Pelletier, G., Martel, C., Archer, D. F., & Utian, W. H. (2017) · Menopause · doi:10.1097/gme.0000000000000808 · Cited by 82
Eriksson, A. L., Lorentzon, M., Mellström, D., Vandenput, L., Swanson, C., Andersson, N., Hammond, G. L., Jakobsson, J., Rane, A., Orwoll, E. S., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0679 · Cited by 101
Sex steroids in Sjögren’s syndrome
Konttinen, Y. T., Fuellen, G., Bing, Y., Porola, P., Stegaev, V., Trokovic, N., Falk, S. S. I., Liu, Y., Szodoray, P., & Takakubo, Y. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.01.004 · Cited by 78
Lipid-activated transcription factors control bile acid glucuronidation
Barbier, O., Trottier, J., Kaeding, J., Caron, P., & Verreault, M. (2009) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-0001-5 · Cited by 85
Sex Differences in UDP-Glucuronosyltransferase 2B17 Expression and Activity
Gallagher, C. J., Balliet, R. M., Sun, D., Chen, G., & Lazarus, P. J. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.035345 · Cited by 78
Regulation of UDP-Glucuronosyltransferase 1A1 Expression and Activity by MicroRNA 491-3p
Dluzen, D. F., Sun, D., Salzberg, A. C., Jones, N. D., Bushey, R. T., Robertson, G. P., & Lazarus, P. J. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.210658 · Cited by 75
He, X., Hesse, L. M., Hazarika, S., Masse, G., Harmatz, J. S., Greenblatt, D. J., & Court, M. H. (2009) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03519.x · Cited by 75
Vandenput, L., Labrie, F., Mellström, D., Swanson, C., Knutsson, T., Peeker, R., Ljunggren, Ö., Orwoll, E., Eriksson, A. L., Damber, J.-E., et al. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.061018 · Cited by 71
Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer
Lucarelli, G. T., Rutigliano, M., Galleggiante, V., Giglio, A., Palazzo, S., Ferro, M., Simone, C., Bettocchi, C., Battaglia, M., & Ditonno, P. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1069711 · Cited by 70
Swart, A. C., & Storbeck, K.-H. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.12.009 · Cited by 68
Miners, J. O., Rowland, A., Novak, J. J., Lapham, K., & Goosen, T. C. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107689 · Cited by 67
Xenobiotic-sensing nuclear receptors involved in drug metabolism: a structural perspective
Wallace, B. D., & Redinbo, M. R. (2012) · Drug Metabolism Reviews · doi:10.3109/03602532.2012.740049 · Cited by 69
Gut microbiota is involved in male reproductive function: a review
Lv, S., Huang, J., Luo, Y., Wen, Y., Chen, B., Qiu, H., Chen, H., Yue, T., He, L., Feng, B., et al. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1371667 · Cited by 76
Gauthier-Landry, L., Bélanger, A., & Barbier, O. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.05.009 · Cited by 62
Self-citationSwanson, C., Mellström, D., Lorentzon, M., Vandenput, L., Jakobsson, J., Rane, A., Karlsson, M. G., Ljunggren, Ö., Smith, U., Eriksson, A., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0359 · Cited by 61
Kaushik, A., Vareed, S. K., Basu, S., Putluri, V., Putluri, N., Panzitt, K., Brennan, C. A., Chinnaiyan, A. M., Vergara, I. A., Erho, N., et al. (2013) · Journal of Proteome Research · doi:10.1021/pr401106h · Cited by 59
Androgens and Glucuronidated Androgen Metabolites Are Associated with Metabolic Risk Factors in Men
Vandenput, L., Mellström, D., Lorentzon, M., Swanson, C., Karlsson, M. K., Brandberg, J., Lönn, L., ORWOLL, E. S., Smith, U., Labrie, F., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0252 · Cited by 59
Nadeau, G., Bellemare, J., Audet‐Walsh, É., Flageole, C., Huang, S., Bao, B., Douville, P., Caron, P., Fradet, Y., Lacombe, L., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1049 · Cited by 57
Coordinate Regulation of Hepatic Bile Acid Oxidation and Conjugation by Nuclear Receptors
Trottier, J., Milkiewicz, P., Kaeding, J., Verreault, M., & Barbier, O. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060020t · Cited by 58
The role of UDP-glycosyltransferases in xenobioticresistance
Dimunová, D., Matoušková, P., Podlipná, R., Boušová, I., & Skálová, L. (2022) · Drug Metabolism Reviews · doi:10.1080/03602532.2022.2083632 · Cited by 57
Master regulation of bile acid and xenobiotic metabolism via the FXR, PXR and CAR trio
Modica, S. (2009) · Frontiers in bioscience · doi:10.2741/3563 · Cited by 60
Ménard, V., Eap, O., Harvey, M., Guillemette, C., & Lévesque, É. (2009) · Human Mutation · doi:10.1002/humu.21054 · Cited by 57
Chouinard, S., Pelletier, G., Bélanger, A., & Barbier, O. (2004) · Endocrine Research · doi:10.1081/erc-200044014 · Cited by 57
Kaeding, J., Bouchaert, E., Bélanger, J., Caron, P., Chouinard, S., Verreault, M., Larouche, O., Pelletier, G., Staels, B., Bélanger, A., et al. (2008) · Biochemical Journal · doi:10.1042/bj20071136 · Cited by 56
Schulze, J. J., Lorentzon, M., Ohlsson, C., Lundmark, J., Roh, H., Rane, A., & Ekström, L. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3282fad38a · Cited by 55
Chouinard, S., Tessier, M., Vernouillet, G., Gauthier, S., Labrie, F., Barbier, O., & Bélanger, A. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.015891 · Cited by 54
Erichsen, T. J., Aehlen, A., Ehmer, U., Kalthoff, S., Manns, M. P., & Strassburg, C. P. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.01.010 · Cited by 54
Chouinard, S., Pelletier, G., Bélanger, A., & Barbier, O. (2006) · Endocrinology · doi:10.1210/en.2006-0229 · Cited by 53
New frontiers in androgen biosynthesis and metabolism
Penning, T. M. (2010) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e3283381a31 · Cited by 51
Jin, Y., Duan, L., Lee, S. H., Kloosterboer, H. J., Blair, I. A., & Penning, T. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809465200 · Cited by 50
Radical prostatectomy: Influence on serum and urinary androgen levels
Olsson, M., Ekström, L., Schulze, J. J., Kjellman, A., Akre, O., Rane, A., & Gustafsson, O. (2009) · The Prostate · doi:10.1002/pros.21053 · Cited by 49
Grosse, L., Pâquet, S., Caron, P., Fazli, L., Rennie, P. S., Bélanger, A., & Barbier, O. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1462 · Cited by 49
Androgens in prostate cancer: A tale that never ends
Hou, Z., Huang, S., & Li, Z. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.04.010 · Cited by 51
Paitz, R. T., & Bowden, R. M. (2009) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2009.01.018 · Cited by 49
Stromal TGF-β signaling induces AR activation in prostate cancer
Yang, F., Chen, Y., Shen, T., Guo, D., Dakhova, O., Ittmann, M., Creighton, C. J., Zhang, Y., Dang, T. D., & Rowley, D. R. (2014) · Oncotarget · doi:10.18632/oncotarget.2536 · Cited by 48
Ginsberg, G., Guyton, K. Z., Johns, D. O., Schimek, J., Angle, K., & Sonawane, B. R. (2010) · Critical Reviews in Toxicology · doi:10.3109/10408441003742895 · Cited by 47
Combined data of intravaginal prasterone against vulvovaginal atrophy of menopause
Labrie, F., Archer, D. F., Martel, C., Vaillancourt, M., & Montesino, M. (2017) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000910 · Cited by 47
Audet‐Walsh, É., Yee, T., Tam, I. S., & Giguère, V. (2017) · Endocrinology · doi:10.1210/en.2016-1926 · Cited by 49
Valentini, A., Biancolella, M., Amati, F., Gravina, P., Miano, R., Chillemi, G., Farcomeni, A., Bueno, S., Vespasiani, G., Desideri, A., et al. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.014662 · Cited by 45
Suvorov, A., & Takser, L. (2009) · Environmental Health Perspectives · doi:10.1289/ehp.0901031 · Cited by 44
Non-steroidal anti-inflammatory drugs interact with testosterone glucuronidation
Sten, T., Finel, M., Ask, B., Rane, A., & Ekström, L. (2009) · Steroids · doi:10.1016/j.steroids.2009.07.004 · Cited by 43
Okano, M., Ueda, T., Nishitani, Y., Kano, H., Ikekita, A., & Kageyama, S. (2012) · Drug Testing and Analysis · doi:10.1002/dta.1394 · Cited by 42
GnRH agonists and the rapidly increasing use of combined androgen blockade in prostate cancer
Labrie, F. (2014) · Endocrine Related Cancer · doi:10.1530/erc-13-0165 · Cited by 42
Margaillan, G., Lévesque, É., & Guillemette, C. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.09.021 · Cited by 41
Labrie, F., Cusan, L., Gomez, J., Martel, C., Bérubé, R., Bélanger, P., Chaussade, V., Deloche, C., & Leclaire, J. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.02.003 · Cited by 39
Belledant, A., Hovington, H., Garcia, L., Caron, P., Brisson, H., Villeneuve, L., Simonyan, D., Têtu, B., Fradet, Y., Lacombe, L., et al. (2015) · European Urology · doi:10.1016/j.eururo.2015.06.054 · Cited by 40
Dehydroepiandrosterone, androgens and the mammary gland
Labrie, F. (2006) · Gynecological Endocrinology · doi:10.1080/09513590600624440 · Cited by 39
MicroRNA regulation of the major drug-metabolizing enzymes and related transcription factors
Dluzen, D. F., & Lazarus, P. J. (2015) · Drug Metabolism Reviews · doi:10.3109/03602532.2015.1076438 · Cited by 40
Sex steroid metabolism in the regulation of bone health in men
Vandenput, L., & Ohlsson, C. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.03.067 · Cited by 37
Labrie, F., Bèlanger, A., Labrie, C., Candas, B., Cusan, L., & Gomez, J.-L. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.02.007 · Cited by 36
Androgen Metabolism and Response in Prostate Cancer Anti-Androgen Therapy Resistance
Zhang, H., Yi, Z., Xing, Z., Sah, R. K., Hu, J., & Hu, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113521 · Cited by 43
Sun, C., Huo, D., Southard, C., Nemesure, B. B., Hennis, A. J. M., Leske, M. C., Wu, S., Witonsky, D., Olopade, O. I., & Rienzo, A. D. (2011) · Human Genetics · doi:10.1007/s00439-011-1025-6 · Cited by 36
Correlation between circulatory, local prostatic, and intra‐prostatic androgen levels
Olsson, M., Ekström, L., Guillemette, C., Bélanger, A., Rane, A., & Gustafsson, O. (2010) · The Prostate · doi:10.1002/pros.21307 · Cited by 35
Margiotta‐Casaluci, L., Courant, F., Antignac, J., Bizec, B. L., & Sumpter, J. P. (2013) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2013.06.017 · Cited by 35
Tian, M., Wang, Y., Wang, X., Wang, H., Liu, L., Zhang, J., Nan, B., Shen, H., & Huang, Q. (2020) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2020.124904 · Cited by 35
Calcitrol (1α,25-dihydroxyvitamin D3) inhibits androgen glucuronidation in prostate cancer cells
Kaeding, J., Bélanger, J., Caron, P., Verreault, M., Bélanger, A., & Barbier, O. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0455 · Cited by 35
Witchel, S. F., & Topaloglu, A. K. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47912-7.00017-2 · Cited by 42
du Toit, T., & Swart, A. C. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.09.026 · Cited by 34
Terakura, S., Murata, M., Nishida, T., Emi, N., Akatsuka, Y., Riddell, S. R., Morishima, Y., Kodera, Y., & Naoe, T. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05427.x · Cited by 33
Ekström, L., Johansson, M. H., & Rane, A. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.049197 · Cited by 33
Urinary steroid profile in relation to the menstrual cycle
Schulze, J. J., Suominen, T., Bergström, H., Ericsson, M., Bergman, L. B., & Ekström, L. (2020) · Drug Testing and Analysis · doi:10.1002/dta.2960 · Cited by 33
Metadata
- Authors
- Bélanger, A., Pelletier, G., Labrie, F., Barbier, O., & Chouinard, S.
- Affiliations
- Centre hospitalier de l'Université Laval (CA)
- Corresponding author
- Bélanger, Alain
- ORCID
- Barbier, Olivier
- Venue
- Trends in Endocrinology & Metabolism
- Publisher
- Elsevier BV
- Published
- 2003-12
- Volume
- 14
- Issue
- 10
- Pages
- 473-479
- ISSN
- 1043-2760 (ISSN-L)
- OpenAlex
- W1988871942
- Cited by
- 235
- References
- 74
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 8 · 2023: 5 · 2022: 12 · 2021: 9 · 2020: 8 · 2019: 8 · 2018: 8 · 2017: 17 · 2016: 11 · 2015: 13 · 2014: 11 · 2013: 18 · 2012: 8
- FWCI
- 0.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Trends in Endocrinology and Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- androgen metabolism, UDP-glucuronosyltransferase, UGT2B7, UGT2B15, UGT2B17, dihydrotestosterone, androstanediol, androstanediol glucuronide, glucuronidation, 3β-hydroxysteroid dehydrogenase, 17β-hydroxysteroid dehydrogenase, 5α-reductase, prostate, skin
- MeSH terms
- Androgens, Humans, Isoenzymes, Male, Prostate, Prostatic Neoplasms, Skin, Glucuronosyltransferase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review